These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1398999)

  • 61. Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma S) regulon.
    Coynault C; Robbe-Saule V; Norel F
    Mol Microbiol; 1996 Oct; 22(1):149-60. PubMed ID: 8899717
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination.
    Schödel F; Kelly SM; Peterson DL; Milich DR; Curtiss R
    Infect Immun; 1994 May; 62(5):1669-76. PubMed ID: 8168928
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of exposure to a delta cya/delta crp mutant of Salmonella typhimurium on the subsequent colonization of swine by the wild-type parent strain.
    Coe NE; Wood RL
    Vet Microbiol; 1992 Jun; 31(2-3):207-20. PubMed ID: 1626370
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Construction of attenuated Salmonella choleraesuis vaccine strain expressing recombinant antigen of Shiga-like toxin Escherichia coli].
    Man X; Wu B; Luo Y; Yu T; Zhao Z; Xu Y; Guo A; Chen H
    Wei Sheng Wu Xue Bao; 2009 Apr; 49(4):518-23. PubMed ID: 19621641
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A DIVA vaccine for cross-protection against Salmonella.
    Bearson BL; Bearson SM; Kich JD
    Vaccine; 2016 Mar; 34(10):1241-6. PubMed ID: 26836212
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The use of live attenuated Salmonella for oral vaccination.
    Chatfield S; Roberts M; Li J; Starns A; Dougan G
    Dev Biol Stand; 1994; 82():35-42. PubMed ID: 7958481
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunity conferred by Aro- Salmonella live vaccines.
    Hormaeche CE; Joysey HS; Desilva L; Izhar M; Stocker BA
    Microb Pathog; 1991 Feb; 10(2):149-58. PubMed ID: 1890952
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of a Salmonella choleraesuis isolate after repeated neutrophil exposure.
    Roof MB; Kramer TT; Roth JA; Minion FC
    Am J Vet Res; 1992 Aug; 53(8):1328-32. PubMed ID: 1510308
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunizing efficacy of aromatic-dependent Salmonella dublin in mice and calves.
    Mukkur TK; Walker KH; Jones D; Wronski E; Love DN
    Comp Immunol Microbiol Infect Dis; 1991; 14(3):243-56. PubMed ID: 1959320
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification and characterization of TnphoA mutants of Salmonella that are unable to pass through a polarized MDCK epithelial cell monolayer.
    Finlay BB; Starnbach MN; Francis CL; Stocker BA; Chatfield S; Dougan G; Falkow S
    Mol Microbiol; 1988 Nov; 2(6):757-66. PubMed ID: 2850443
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nonrecombinant and recombinant avirulent Salmonella vaccines for poultry.
    Curtiss R; Hassan JO
    Vet Immunol Immunopathol; 1996 Nov; 54(1-4):365-72. PubMed ID: 8988881
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.
    Huang C; Liu Q; Luo Y; Li P; Liu Q; Kong Q
    Vaccine; 2016 Aug; 34(36):4285-92. PubMed ID: 27423383
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of a live Salmonella choleraesuis vaccine by intranasal challenge.
    Hanna J; McCracken R; O'Brien JJ
    Res Vet Sci; 1979 Mar; 26(2):216-9. PubMed ID: 262604
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Salmonella dublin virulence plasmid does not modulate early T-cell responses in mice.
    Guilloteau LA; Lax AJ; MacIntyre S; Wallis TS
    Infect Immun; 1996 Jan; 64(1):222-9. PubMed ID: 8557343
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen.
    Dunstan SJ; Simmons CP; Strugnell RA
    Infect Immun; 1998 Feb; 66(2):732-40. PubMed ID: 9453634
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Different appearance of gamma delta T cells during salmonellosis between Ityr and Itys mice.
    Emoto M; Naito T; Nakamura R; Yoshikai Y
    J Immunol; 1993 Apr; 150(8 Pt 1):3411-20. PubMed ID: 8468480
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Immunogenic properties of S. choleraesuis for pigs].
    Sluzewska M; Truszczyński M
    Pol Arch Weter; 1975; 17(4):599-608. PubMed ID: 1237131
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relevance of inoculation route to virulence of three Salmonella spp. strains in mice.
    Nnalue NA
    Microb Pathog; 1991 Jul; 11(1):11-8. PubMed ID: 1795625
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Oral vaccination of calves with an aromatic-dependent Salmonella dublin (O9,12) hybrid expressing O4,12 protects against S. dublin (O9,12) but not against Salmonella typhimurium (O4,5,12).
    Segall T; Lindberg AA
    Infect Immun; 1993 Apr; 61(4):1222-31. PubMed ID: 7681042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.